Infection Control Opportunity Garwood Medical Devices focuses on advancing infection control through innovative electrical stimulation treatments for peri-prosthetic infections. This presents a sales opportunity to hospitals and surgical centers looking to reduce implant-related infection rates and postoperative complications, particularly in orthopedic and prosthetic programs.

Patent Tech Advantage With patented BioPrax technology targeting implant infections and antibiotic-resistant bacteria, emphasize the defensible IP and differentiated solution when engaging medical device procurement teams and orthopedics directors seeking innovative, patent-protected technologies.

Growth Capital Backing Recent VC financing signals momentum and validation of the business case. Use this to position Garwood as a growing partner with potential for larger-scale deployments, early-adopter programs, and pilot opportunities in health systems building infection-control capabilities.

Growth & Scale Potential Revenue is in the low-to-mid single-digit millions with a lean team. Target mid-market and regional health systems looking for scalable, cost-conscious infection-control solutions that can integrate with existing surgical workflows and device ecosystems.

Tech Stack Synergies Leveraging common enterprise tools and web technologies, identify opportunities for integration with hospital data and infection-tracking software, remote monitoring, or outcomes analytics partnerships to demonstrate measurable infection-reduction results and justify adoption.